Catheter ablation for ventricular tachycardia bests non-ablative approaches | J Interv Card Electrophysiol

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway 

  • Meta-analysis results of three trials show odds of ventricular tachycardia (VT) recurrence are 53% reduced with ablation vs non-ablation therapies in patients with ischemic heart disease. 

Key results

  • Three trials, 262 patients had ablation (n=129) or non-ablative interventions (beta-blockers±antiarrhythmics) (n=133). 
  • Cumulative OR for recurrent VT, 0.471 (95% CI, 0.176–1.257) for ablation vs non-ablative therapies.
  • Cumulative OR for death, 0.766 (95% CI, 0.351–1.674). 

Study design

  • Meta-analysis, RCTs. 

Why this matters

  • Catheter ablation may be better than non-ablative strategies at preventing implantable cardioverter defibrillator shocks for ventricular arrhythmias.